Top

Published in:

Open Access 01-12-2011 | Poster presentation

Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center

Authors: G Espada, SM Meiorin, L Guerini, M Alvarez, Giupponi

Published in: Pediatric Rheumatology | Special Issue 1/2011

Excerpt

Anti-TNF agents are frequently used in the treatment of severe rheumatic disorders in childhood mainly Juvenile Idiopathic arthritis. Despite good clinical efficacy of this therapy, practitioners must remain alert for potential side effects, particularly after prolonged use (infections, malignancy and autoinmune events) . …

Title: Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center
Authors: G Espada
SM Meiorin
L Guerini
M Alvarez
Giupponi
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Pediatric Rheumatology / Issue Special Issue 1/2011
Electronic ISSN: 1546-0096
DOI: https://doi.org/10.1186/1546-0096-9-S1-P68

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2011

Recurrent poliserositis succesfully treated with IL-1 receptor antagonist Anakinra

Plasmapheresis and Cyclophosphamide therapy in an eight year old girl with cerebral manifestation of systemic lupus erythematodes

Quality of life in patients with juvenile arthritis: adalimumab might make a difference

The efficacy and safety of Tocilizumab in adults with refractory systemic onset JIA

Juvenile idiopathic arthritis (JIA): can an integrated medicine be possible?

Think about the joints